Tesofensine is a triple monoamine reuptake inhibitor (MRI) that modulates dopaminergic, noradrenergic, and serotonergic neurotransmission. It selectively inhibits the presynaptic reuptake of dopamine (DA), norepinephrine (NE), and serotonin (5-HT), influencing neurotransmitter availability and receptor interactions.
This compound undergoes hepatic metabolism via cytochrome P450 enzymes (CYP3A4), producing active metabolites with prolonged systemic activity.
Reviews
There are no reviews yet.